Search results
Showing results for
Dr Fadi Issa has received a gentleMACST Octo Dissociator from global biotechnology company Miltenyi Biotec following a competition draw.
Faculty development
Faculty development
Clinical course
Clinical course
Patient and public engagement
Information about public and patient engagement with the study
News and publications
Latest news and publications
VANGUARD PATH
VANGUARD PATH homepage
Background
Background
Study aims
Information on the study and its aims
Digital pathology and AI – Advances in techniques and technology
Description of advances in pathology